Historically, the method for producing glycoconjugate vaccines has been lengthy and complex with low yields, requiring two separate fermentation runs and numerous purification steps, as well as a tedious chemical conjugation step. In contrast, GlycoVaxyn AG's vaccine conjugates are produced in recombinant E. coli using a single fermentation run that includes the conjugation process, and subsequent downstream purifications.
Grabenstrasse 3
8952 Schlieren
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
UroGen’s Zusduri was approved despite an advisory committee vote recommending against it in May. It is the first approved drug for a type of recurring bladder cancer.
The Belgian drugmaker is boosting its biologics capacity over the pond.
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
Study to add to safety and tolerability data for infused formulation and may help identify optimal dose for future pivotal trial.
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
Recent moves in the industry include changes at the top at iOnctura and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.
Study to add to safety and tolerability data for infused formulation and may help identify optimal dose for future pivotal trial.
